Acadia pharmaceuticals inc. (ACAD)
Income statement / Quarterly
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Jun'13Mar'13Dec'12Sep'12Jun'12Mar'12Dec'11Sep'11Jun'11Mar'11Sep'10Jun'10
Revenues
Product sales, net

-

-

-

-

-

-

-

-

-

-

-

-

15,286

-

5,268

97

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Collaborative revenue

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

4

-

39

1

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Total revenues

90,068

98,326

94,586

83,205

62,959

59,571

58,305

57,063

48,868

43,562

35,578

30,475

15,286

11,962

5,268

97

4

17

39

1

4

47

15

28

30

37

240

451

417

380

3,478

599

450

588

584

460

435

2,301

2,297

Operating expenses
Cost of product sales

2,799

3,020

2,416

2,958

2,950

2,823

3,839

3,562

2,153

2,455

2,135

2,224

2,263

-

845

526

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

License fees and royalties

2,175

2,314

2,273

2,037

1,630

1,569

1,536

1,516

1,332

1,248

1,078

982

675

-

475

248

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Research and development

72,636

57,520

62,622

67,320

52,923

48,183

53,112

46,592

39,276

43,179

36,421

34,180

35,409

30,218

25,813

20,478

22,775

20,466

18,729

18,379

16,295

18,183

16,952

13,799

11,668

7,926

7,254

7,112

4,430

4,901

4,400

4,472

5,021

4,424

4,158

4,315

4,412

4,965

5,041

Selling, general and administrative

101,973

91,871

72,696

67,981

93,090

74,271

61,089

69,472

60,926

66,689

61,588

61,125

65,660

57,663

50,534

50,768

27,491

22,616

20,308

21,119

24,261

10,419

8,057

7,952

6,320

4,276

3,797

2,496

2,151

2,298

1,485

1,556

1,660

1,478

1,519

2,729

1,884

1,578

1,552

Total operating expenses

179,583

154,725

140,007

140,296

150,593

126,846

119,576

121,142

103,687

113,571

101,222

98,511

104,007

90,193

77,667

72,020

50,266

45,582

39,037

39,498

40,556

28,602

25,009

21,751

17,988

12,202

11,051

9,608

6,581

7,199

5,885

6,028

6,681

5,902

5,677

7,044

6,296

6,543

6,593

Loss from operations

-89,515

-56,399

-45,421

-57,091

-87,634

-67,275

-61,271

-64,079

-54,819

-70,009

-65,644

-68,036

-88,721

-78,231

-72,399

-71,923

-50,262

-45,565

-38,998

-39,497

-40,552

-28,555

-24,994

-21,723

-17,958

-12,165

-10,811

-9,157

-6,164

-6,819

-2,407

-5,429

-6,231

-5,314

-5,093

-6,584

-5,861

-4,242

-4,296

Interest income, net

2,989

3,272

2,432

2,527

2,934

1,670

1,229

1,279

1,170

1,107

1,063

993

963

876

786

601

500

111

92

119

177

189

208

228

130

116

116

76

41

9

5

10

13

14

17

28

28

15

8

Other expense

1,497

9

747

12

229

-

-1,720

247

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Loss before income taxes

-88,023

-52,636

-42,242

-54,576

-84,929

-65,478

-61,762

-63,047

-53,649

-68,902

-64,581

-67,043

-87,758

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Income tax expense

-

400

-264

365

375

14

376

219

647

-31

667

398

85

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net loss

-88,023

-53,036

-41,978

-54,941

-85,304

-65,492

-62,138

-63,266

-54,296

-68,871

-65,248

-67,441

-87,843

-78,696

-71,613

-71,322

-49,762

-45,784

-38,906

-39,378

-40,375

-28,366

-24,786

-21,495

-17,828

-12,049

-10,695

-9,081

-6,123

-6,810

-2,402

-5,419

-6,218

-5,300

-5,076

-6,556

-5,833

-4,227

-4,288

Net loss per common share, basic and diluted

-0.57

-0.34

-0.29

-0.38

-0.59

-0.49

-0.50

-0.51

-0.44

-0.56

-0.53

-0.55

-0.72

-0.65

-0.61

-0.63

-0.45

-0.45

-0.39

-0.39

-0.40

-0.29

-0.25

-0.22

-0.19

-0.13

-0.12

-0.11

-0.08

-0.12

-0.04

-0.10

-0.12

-0.10

-0.10

-0.12

-0.12

-0.11

-0.11

Weighted average common shares outstanding, basic and diluted

155,368

154,595

145,906

144,314

143,981

131,686

125,009

124,910

124,727

124,143

122,484

122,122

121,651

121,281

117,497

113,308

111,346

101,218

100,756

100,349

100,197

97,479

99,497

99,048

92,968

91,198

89,504

83,410

78,748

60,689

53,911

52,961

52,903

52,888

52,800

52,677

50,367

38,383

38,347

Comprehensive loss

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-5,080

-7,083

-5,808

-

-